Lv41
470 积分 2024-11-15 加入
Genomic profiling informs diagnoses and treatment in vascular anomalies
6天前
已完结
Dalpiciclib plus endocrine therapy in women with HR+/HER2− advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial
21天前
已完结
Peripheral PD-1⁺CD8⁺ T-cell TCR Dynamics during Radiotherapy Predict Survival in Unresectable Locally Advanced Non-Small Cell Lung Cancer
21天前
已关闭
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in NSCLC
28天前
已关闭
Circulating tumor DNA as a biomarker in early phase clinical trials
29天前
已完结
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial
30天前
已完结
The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancer
1个月前
已完结
Monitoring minimal residual disease using circulating tumor DNA in patients treated long-term with PARP inhibitors for ovarian cancer
1个月前
已关闭
Phase II investigation of pembrolizumab in combination with bevacizumab and oral cyclophosphamide in patients with high grade ovarian cancer and surgical or molecular minimal residual disease after frontline therapy
1个月前
已关闭
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2个月前
已完结